Details werden geladen...
Coty Announces Agreement With Kering for Early Transition of Gucci Beauty License
Coty to receive approximately $400 million in consideration for the early termination plus sale of sufficient Gucci Beauty inventory to support the transition Coty to continue operating Gucci
Ähnliche Seiten
Coty exits Gucci license early | The Manila Times
https://www.manilatimes.net/2026/07/09/business/foreign-business/coty-exits-gucci-license-early/2381002
L'ORÉAL: L'Oréal enters a 50-year exclusive worldwide beauty licence with Kering for the Gucci brand
https://www.finanznachrichten.de/nachrichten-2026-07/68967142-l-oreal-l-oreal-enters-a-50-year-exclusive-worldwide-beauty-licence-with-kering-for-the-gucci-brand-399.htmVect-Horus announces collaboration and license option agreement with Servier to develop targeted oligonucleotide therapeutics for rare CNS diseases | The Manila Times
https://www.manilatimes.net/2026/06/30/tmt-newswire/globenewswire/vect-horus-announces-collaboration-and-license-option-agreement-with-servier-to-develop-targeted-oligonucleotide-therapeutics-for-rare-cns-diseases/2375405Astex Announces Exclusive Research Collaboration and License Agreement with Genentech for Breast Cancer Therapy Program | The Manila Times
https://www.manilatimes.net/2026/07/06/tmt-newswire/globenewswire/astex-announces-exclusive-research-collaboration-and-license-agreement-with-genentech-for-breast-cancer-therapy-program/2378788Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE | The Manila Times
https://www.manilatimes.net/2026/06/22/tmt-newswire/pr-newswire/antengene-announces-exclusive-license-agreement-with-mpm-bioimpact-established-k2-therapeutics-for-atg-106-and-option-for-undisclosed-bispecific-tce/2369714